Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.810
-0.040 (-2.16%)
Apr 29, 2026, 3:10 PM EDT - Market open
Milestone Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Milestone Pharmaceuticals stock have an average target of 8.00, which predicts a 341.99% increase from the current stock price of 1.81.
Price Target: $8.00 (+341.99%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 6, 2026.
Analyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +341.99% | Jan 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +341.99% | Dec 16, 2025 |
| TD Cowen | TD Cowen | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +341.99% | Dec 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $8 | Strong Buy | Maintains | $5 → $8 | +341.99% | Dec 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $4 | Buy | Initiates | $4 | +120.99% | Sep 11, 2025 |
Financial Forecast
Revenue This Year
46.61M
from 1.55M
Increased by 2,915.14%
Revenue Next Year
29.72M
from 46.61M
Decreased by -36.25%
EPS This Year
-0.53
from -0.75
EPS Next Year
-0.87
from -0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 87.7M | 42.0M | ||||||
| Avg | 46.6M | 29.7M | ||||||
| Low | 3.9M | 20.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5,571.1% | -9.9% | ||||||
| Avg | 2,915.1% | -36.2% | ||||||
| Low | 153.6% | -55.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.06 | -0.67 | ||||
| Avg | -0.53 | -0.87 | ||||
| Low | -1.13 | -1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.